Grifols is a global healthcare company founded in Barcelona, with more than 100 years of history, dedicated to improving the health and well-being of people around the world.
We are an industry leader in the production of plasma-derived medicines and transfusion medicine, with more than 21,000 employees across 30 countries.
Our business continues to grow, we remain committed to a long-term, sustainable and responsible vision.
Commitment to patients
The patients we serve around the world are able to lead better lives thanks to plasma-derived medicines and donors. Patients inspire the work we do every day.
The Grifols Hemophilia Awareness Global Awards (GHAGA)
A periodical award focused on encouraging health care providers, hemophilia treatment centers as well as hemophilia societies to submit proposals that would contribute to improving the care of hemophilia patients and their quality of life.
November 15, 2019
Grifols completes its debt-refinancing in record time and with strong acceptance for EUR 5,800 million
November 13, 2019
Grifols and Shanghai RAAS obtain authorization for their strategic alliance in China
Our business is organized into four divisions: Bioscience, Diagnostic, Hospital and Bio Supplies.
We are committed to a long-term vision that creates a sustainable, positive impact on the communities in which we operate.
Since the foundation of Grifols, our on-going innovation has helped shape industry standards in the plasma medicines sector.
Do you want to know more about one of the leading healthcare companies? Here you will find all the information about Grifols and our commitment to improving the health and well-being of people around world.
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?